News

Press Center


17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax- was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More
Topics Petrovax Pharm 23.03.2020
The Foundation is now announcing the launch of new large-scale initiatives to help non-profits and their beneficiaries to survive the next few months
More
Topics COVID-19 / donations / coronavirus / Vladimir Potanin 03.12.2018
The first place in the nomination «Medicine of choice for the treatment and prevention of SARS and influenza among children» was granted to «Polyoxidonium», produced by NGO Petrovax Pharm.
More
Topics Petrovax Pharm 
06.08.2018
In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.
More
Topics Petrovax Pharm